News Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia | The Motley Fool Novavax (NASDAQ:NVAX) announced on Wednesday that it has reached an agreement to provide the Australian government…Super UserNovember 8, 2020
News Novavax Announces Facility Expansion to Support Global Vaccine Development | Novavax Inc. – IR Site GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company…Super UserNovember 2, 2020
BHI Weekly News Archives 429th Edition, October 28, 2020 BioHealth Innovation If you are having trouble viewing this email, please click here October 28,…Super UserNovember 2, 2020
News What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal Through a partnership with NIH, D.C. virtual reality startup Floreo is expanding from autism spectrum…Super UserNovember 2, 2020
News Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch Sep 05, 2020 (IssueWire via COMTEX) -- San Diego, Sep 5, 2020 (Issuewire.com) - Jaan…Super UserNovember 2, 2020
News Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN) ROCKVILLE, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today…Super UserNovember 2, 2020
News Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire GAITHERSBURG, Md.--(BUSINESS WIRE)--Neuraly, Inc., a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders,…Super UserNovember 2, 2020
News Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace Three Emmes employees were among the co-authors of the recent report, "Safety and Immunogenicity of…Super UserNovember 2, 2020
News JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz MADISON, Wis. and CAMBRIDGE, Mass., Oct. 27, 2020 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection…Super UserNovember 2, 2020
News REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc. ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology…Super UserNovember 2, 2020